TY - JOUR
T1 - Implementation of Multiple Evidence-Based Heart Failure Therapies
AU - Latif, Azka
AU - Ahsan, Muhammad Junaid
AU - Lateef, Noman
AU - Kapoor, Vikas
AU - Tran, Amy
AU - Abusnina, Waiel
AU - Lundgren, Scott
AU - Goldsweig, Andrew
AU - Ahsan, Muhammad Zoraiz
AU - Mirza, Mohsin
N1 - Funding Information:
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Publisher Copyright:
© 2022 Elsevier Inc.
PY - 2022/10
Y1 - 2022/10
N2 - Despite the advancements in the management of heart failure, acute heart failure is one of the most common causes of mortality and morbidity. In light of the financial burden imposed by heart failure hospitalizations on the health care system, this area remains the focus of research, clinical advances, and policy changes aimed at improving the quality of care and outcomes. Despite practice guidelines, high-quality trial data, and consensus statements, barriers to therapy remain. The barriers related to physician, patient, economic, health care system, and logistical factors prevent widespread adoption of available therapeutics. In this review article, we outline guidelines directed therapies for heart failure, challenges associated with their implementation, and potential solutions to these challenges to help reduce mortality and improve clinical outcomes in this patient population.
AB - Despite the advancements in the management of heart failure, acute heart failure is one of the most common causes of mortality and morbidity. In light of the financial burden imposed by heart failure hospitalizations on the health care system, this area remains the focus of research, clinical advances, and policy changes aimed at improving the quality of care and outcomes. Despite practice guidelines, high-quality trial data, and consensus statements, barriers to therapy remain. The barriers related to physician, patient, economic, health care system, and logistical factors prevent widespread adoption of available therapeutics. In this review article, we outline guidelines directed therapies for heart failure, challenges associated with their implementation, and potential solutions to these challenges to help reduce mortality and improve clinical outcomes in this patient population.
UR - http://www.scopus.com/inward/record.url?scp=85136252393&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85136252393&partnerID=8YFLogxK
U2 - 10.1016/j.cpcardiol.2022.101293
DO - 10.1016/j.cpcardiol.2022.101293
M3 - Review article
C2 - 35753401
AN - SCOPUS:85136252393
SN - 0146-2806
VL - 47
JO - Current Problems in Cardiology
JF - Current Problems in Cardiology
IS - 10
M1 - 101293
ER -